In addition, the anti-tumor effects of DNMTi -zebularine depend on the co-existence of CD4+ and CD8+ T lymphocytes and the presence of CD4+ T cells is necessary for CTLs to kill tumor cells. This evidence concerns the gene CD4 and neoplasm.